Kevin Weinstein joined SPH Analytics in 2020 as President of the Population Health business unit. Prior to joining SPH Analytics, Kevin served as the Chief Growth Officer of Apervita, CEO of Analyte Health, and Chief Growth Officer at Valence Health. He also served in roles at ZirMed and Allscripts. Kevin received his MBA from Northwestern’s Kellogg School of Management and a BA in English from Colgate University.